Jun and MAP kinases are activated by cholecystokinin in the pancreatic carcinoma cell line KP-1N

Pancreas

Volumn 16, Issue 4, 1998, Pages 499-504

  Tateishi, Kayoko ^a   Funakoshi, Akihiro ^b   Misumi, Yoshio ^a   Matsuoka, Yuji ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

c Jun kinase; Cell growth; Cholecystokinin; Mitogen activated protein kinase

Indexed keywords

CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; GASTRIN 17; LOXIGLUMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; TYROSINE;

ARTICLE; BINDING AFFINITY; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0031957525     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199805000-00007     Document Type: Article

References (19)

1. Smith JP, Kramer ST, Solomon TE. CCK stimulates growth of six human pancreatic cancer cell lines in serum-tree medium. Regul Pept 1991;32:341-9.
2. Sethi T, Rozengurt E. Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res 1991; 51:3621-3.
3. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9:726-35.
4. Malarkey K, Belham CM, Paul A, et al. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J 1995;309:361-75.
5. 42MAP. Oncogene 1994;9:861-7.
6. Todisco A, Takeuchi Y, Seva C, Dickinson CJ, Yamada T. Gastrin and glycine-extended progastrin processing intermediates induce different programs of early gene activation. J Biol Chem 1995; 270:28337-41.
7. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993;7:2135-48.
8. Derijard B, Hibi M, Wu I-H, et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025-37.
9. Kallunki T, Su B, Tsigelny I, et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994;8:2996-3007.
10. Dabrowski A, Grady T, Logsdon CD, Williams JA. Jun kinases are rapidly activated by cholecystokinin in rat pancreas both in vitro and in vivo. J Biol Chem 1996;271:5686-90.
11. Funakoshi A, Kono A. Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice. Gastroenterologia Japon 1992;27:78-82.
12. Ikeda Y, Ezaki M, Hayashi I, Yasuda D, Nakayama K, Kono A. Establishment and characterization of human pancreatic cancer cell lines in tissue culture and in nude mice. Jpn J Cancer Res 1990; 81:987-93.
13. Funakoshi A, Tateishi K, Tsuru M, Jimi A, Wakasugi H, Kono A. Acetylcholine regulates pancreastatin secretion from the human pancreastatin-producing cell line (QGP-1N). J Clin Endocrinol Metab 1991;73:151-5.
14. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31-40.
15. Hunter T, Cooper JA. Protein-tyrosine kinases. Annu Rev Biochem 1985;54:897-930.
16. Wank SA. Cholecystokinin receptors. Am J Physiol 1995;269: G628-16.
17. Grunewald K, Lyons J, Frohlich A, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989;43:1037-41.
18. Barbacid M. ras genes. Annu Rev Biochem 1987;56:779-827.
19. Lowy DR, Willumsen BM. Function and regulation of ras. Annu Rev Biochem 1993;62:851-91.